Office of Cancer Survivorship

The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.

Stay up-to-date on everything from OCS @NCICancerSurv

Stay up-to-date on everything from DCCPS LinkedIn

Spotlight

Upcoming Presentation

OCS Director’s Series presents Implementing Patient-Reported Outcomes and Psychosocial Interventions in Diverse Communities of Cancer Survivors

September 2024 – Join the NCI Office of Cancer Survivorship for this OCS Director’s Series webinar on September 17, 2024, from 2-3 p.m. ET. Dr. Frank J. Penedo will present Implementing Patient-Reported Outcomes and Psychosocial Interventions in Diverse Communities of Cancer Survivors, and advocate and survivor Iliana Suarez will share her experiences. Register now.

Request for Information

New Request for Information (RFI) Focuses on Whole Person Research and Whole Person-Based Clinical Care

NCI announces NOT-CA-24-061, Seeking Input to Identify and Explore Experiences Utilizing the Whole Person Perspective and Evidence for Its Value in the Care of People with Cancer. Read more about this RFI.

Publication

Prevalence of Cancer Survivors in the United States

In this new study published in JNCI, NCI Office of Cancer Survivorship Director Dr. Emily Tonorezos and coauthors report updated cancer survivor prevalence estimates, including the proportion of the US population represented by cancer survivors.

UPCOMING PRESENTATION

OCS Director's Series Presents Advancing Research through Cancer Survivorship Clinical Programs

October 2024 – In this upcoming OCS Director’s Series webinar on October 15, 2024, from 2-3 p.m. ET, Dr. Precilla L. Belin, Dr. Anne Blaes, Dr. Sofia F. Garcia, Dr. Sharon Manne, Dr. Larissa Nekhlyudov, Dr. Lidia Schapira, and Dr. Stephanie M. Smith will present Advancing Research through Cancer Survivorship Clinical Programs. Register now.

View More News and Highlights

Funding Opportunities

Notice of Intent to Publish a Funding Opportunity Announcement for Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors

NOFO coming soon

Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers

FIRST RECEIPT DATE: October 11, 2024

Notice of Special Interest (NOSI): Addressing Health Disparities Among Immigrant Populations Through Effective Interventions

EXPIRATION DATE: June 06, 2026

Advancing Healthcare for Older Adults from Populations that Experience Health Disparities

EXPIRATION DATE: January 08, 2028

Featured Media

Improving the Lives of All Cancer Survivors

How Does OCS Define ‘Cancer Survivor'?

About The Office of Cancer Survivorship

An individual is considered a cancer survivor from the time of diagnosis, through the balance of life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.

OCS works to promote a better understanding of unique needs of the growing population of cancer survivors, and to enhance our ability to address them.

Quick Links

Featured Graph and Statistic

Individuals Living with Metastatic Cancer

Researchers at the National Cancer Institute have estimated that 623,405 people in the United States were living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma as of 2018, and that number is expected to increase to 693,452 by the year 2025.

View More Graphs